✦ LIBER ✦

A Phase II Study of Erlotinib as a First-Line Therapy for Patients with Non—Small-Cell Lung Cancer with Favorable Clinical Predictors

✍ Scribed by Dae Ho Lee; Sang-We Kim; Cheolwon Suh; Tak Yun; Heung Tae Kim; Eun Kyung Cho; Jong Seok Lee

Book ID: 114412077
Publisher: CIG Media Group, LP.
Year: 2008
Tongue: English
Weight: 62 KB
Volume: 9
Category: Article
ISSN: 1525-7304
DOI: 10.1016/s1525-7304(11)70863-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase II Trial of Erlotinib As Front-L

A Phase II Trial of Erlotinib As Front-Line Treatment in Clinically Selected Patients With Non–Small-Cell Lung Cancer

✍ Athanasios G. Pallis; Alexandra Voutsina; Nikolaos Kentepozidis; Stylianos Giass 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 374 KB

Clinical effect of erlotinib as first-li

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer

✍ Xin-Hua Xu; Jin Su; Xiang-Yang Fu; Feng Xue; Qiao Huang; Dao-Jun Li; Ming-Qian L 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 232 KB

A phase II study of single-agent gefitin

A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer

✍ Suzuki, R; Hasegawa, Y; Baba, K; Saka, H; Saito, H; Taniguchi, H; Yamamoto, M; M 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB

First-Line Single Agent Treatment With G

First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Phase II Study

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Mok, T. S.K.; Wu, Y.-L.; Yu, C.-J.; Zhou, C.; Chen, Y.-M.; Zhang, L.; Ignacio, J 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 151 KB